CVS Health has delivered a solid share price gain over the past few years, yet the stock has recently pulled back and is now heading into a major breakup of the business. This puts fresh focus on whether the current price makes sense relative to its earnings power. With the shares closing at US$83.85, investors are asking if the recent news and the longer term performance leave the earnings story fully reflected in the valuation or not.
Over the past 3 years, CVS Health has returned 38.7%, which raises the question of how much of the company’s earnings strength is already embedded in the current share price.
The planned split into two listed companies, separating the retail pharmacy operations from insurance and healthcare services, may shift how investors assess future earnings quality, capital needs and risk for each side of the business.
There is a second opinion on CVS Health worth weighing. See what analysts think CVS Health’s shares could be worth.
The stock’s next move may depend on whether CVS Health’s current earnings and their outlook are enough to justify today’s valuation.
If you want a reference point for how other listed companies are being priced on quality and fundamentals right now, it is worth scanning solid balance sheet and fundamentals stocks screener (24 results).
Does CVS Health Look Undervalued on Earnings?
For CVS Health, the P/E ratio is a straightforward way to frame what the market is paying for its current earnings profile. The stock trades on a P/E of 9.7x, which is well below the broader healthcare industry average of about 24.9x and also below the peer group average of roughly 20.3x. On this framework, the price implies a lower earnings multiple than both the sector and similar businesses.
Because the modelled fair P/E, which takes into account CVS Health’s margins, scale, risk profile and sector, sits above the current 9.7x level, the shares screen as undervalued on this measure. Despite the planned 2028 split into two listed companies and the legal disputes around Medicare Advantage ratings, the market multiple still prices CVS Health at a discount to where this framework might place it. Explore the numbers behind CVS Health’s P/E valuation.
The CVS Health Narrative: What Would Justify Today’s Price?
Simply Wall St Narratives pick up where the CVS Health valuation puzzle leaves off by spelling out which growth paths, margin shapes and earnings profiles would need to play out for the stock to be worth materially more or materially less than it is today on the market. Each Narrative links its number to a clear view on how CVS Health’s growth, profitability and risk could evolve, so you can come back to that thesis as fresh information comes through.
Source: finance.yahoo.com
